SEARCH

SEARCH BY CITATION

References

  • 1
    Hofmann AF. The function of bile salts in fat absorption: the solvent properties of dilute micellar solutions of conjugated bile salts. Biochem J 1963; 89: 5768.
  • 2
    Hofmann AF, Borgström B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest 1964; 43: 247257.
  • 3
    Hofmann AF. Thin-layer adsorption chromatography of free and conjugated bile acids on silicic acid. J Lipid Res 1961; 3: 127128.
  • 4
    Borgström B, Lundh G, Hofmann AF. The site of absorption of conjugated bile salts in man. Gastroenterology 1963; 45: 229238.
  • 5
    Sato Y, Ikekawa N. Preparation of chenodeoxycholic acid. J Org Chem 1959; 24: 13671368.
  • 6
    Hofmann AF. The preparation of chenodeoxycholic acid and its glycine and taurine conjugates. Acta Chem Scand 1963; 17: 173186.
  • 7
    Hofmann AF, Mosbach EH. Identification of allodeoxycholic acid as the major component of gallstones induced in the rabbit by 5α-cholestan-3β-ol. J Biol Chem 1964; 239: 28132821.
  • 8
    Jones C, Hofmann AF, Mysels KJ, Roda A. The effect of calcium and sodium ion concentration on the properties of dilute aqueous solutions of glycine conjugated bile salts. J Colloid Interface Sci 1986; 114: 452470.
  • 9
    Gu J-J, Hofmann AF, Ton-Nu H-T, Schteingart CD, Mysels KJ. Solubility of calcium salts of unconjugated and conjugated natural bile acids. J Lipid Res 1992; 33: 635646.
  • 10
    Hofmann AF, Mysels KJ. Bile acid solubility and precipitation in vitro and in vivo: the role of conjugation, pH and Ca2+ ions. J Lipid Res 1992; 33: 617626.
  • 11
    Cummings SA, Hofmann AF. Physiological determinants of biliary calcium secretion in the dog. Gastroenterology 1984; 87: 664673.
  • 12
    Hofmann AF, Szczepanik PA, Klein PD. Rapid preparation of tritium labeled bile acids by enolic exchange on basic alumina containing tritiated water. J Lipid Res 1968; 9: 707713.
  • 13
    Cowen AE, Hofmann AF, Hachey DL, Thomas PJ, Belobaba DTE, Klein PD, et al. Synthesis of 11,12-2H2- and 11,12-3H2-labeled chenodeoxycholic and lithocholic acids. J Lipid Res 1976; 17: 231238.
  • 14
    LaRusso NF, Hoffman NE, Hofmann AF. Validity of using 2,4-3H-labeled bile acids to study bile acid kinetics in man. J Lab Clin Med 1974; 84: 759765.
  • 15
    Sorscher S, Lillienau J, Meinkoth JL, Steinbach JH, Schteingart CD, Feramisco J, et al. Conjugated bile acid uptake by Xenopus Laevis oocytes induced by microinjection with ileal Poly A+ mRNA. Biochem Biophys Res Commun 1992; 186: 14551462.
  • 16
    Duane WC, Schteingart CD, Ton-Nu HT, Hofmann AF. Validation of [22,23-3H]-cholic acid as a stable tracer through conversion to deoxycholic acid in human subjects. J Lipid Res 1996; 37: 431436.
  • 17
    Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver J Biol Chem 1998; 273: 1004610050.
  • 18
    Mita SA, Suzuki H, Akta H, Hayashi H, Onuki R, Hofmann AF, et al. Inhibition of bile acid transport across NTCP and BSEP co-expressing LLC-PK1 cells by cholestasis inducing drugs. Drug Metab Dispos 2006; 34: 15751581.
  • 19
    Kuroki S, Schteingart CD, Hagey LR, Cohen BI, Mosbach EH, Rossi SS, et al. Bile salts of the West Indian manatee, Trichechus Manatus Latirostris: novel bile alcohol sulfates and absence of bile acids. J Lipid Res 1988; 29: 509522.
  • 20
    Hagey LR, Schteingart CD, Ton-Nu H-T, Hofmann AF. Identification of a novel bile acid in the shoebill stork and some herons and its phylogenetic significance J Lipid Res 2002; 43: 685690.
  • 21
    Kakiyama G, Iida T, Goto T, Mano N, Goto J, Nambara T, et al. Identification of a novel bile acid in swans, tree ducks, and geese: 3α,7α,15α-trihydroxy-5β-cholan-24-oic acid. J Lipid Res 2006; 47: 15511558.
  • 22
    Iida T, Hikosaka M, Kakiyama G, Shiraishi K, Schteingart CD, Hagey LR, et al. Potential Bile Acid Metabolites. 25. Synthesis and chemical property of stereoisomeric 3α,7α,16- and 3α,7α,15-trihydroxy-5β-24-oic acids. Chem Pharm Bull 2002; 50: 13271334.
  • 23
    Reschly, EJ, Ai N, Ekins S, Welsh WJ, Hagey LR Hofmann AF, et al. Evolution of the bile salt nuclear receptor FXR in vertebrates. J Lipid Res 2008; 49: 15771587.
  • 24
    Haslewood GAD. The Biological Importance of Bile Salts. Amsterdam, Netherlands: North-Holland Publishing Co.; 1978.
  • 25
    Hjelm RP, Schteingart CD, Hofmann AF, Thiyagarajan P. The structure of conjugated bile salt-fatty acid-monoglyceride mixed colloids: studies by small-angle neutron scattering. J Phys Chem 2000; 104: 197211.
  • 26
    Hofmann AF, ed. The physical chemistry of bile in health and disease. HEPATOLOGY 1984; (Suppl): 1S225S.
  • 27
    Simmonds WJ, Hofmann AF, Theodor E. Absorption of cholesterol from a micellar solution: intestinal perfusion studies in man. J Clin Invest 1967; 46: 874890.
  • 28
    Go VLW, Hofmann AF, Summerskill WHJ. Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique. Gastroenterology 1970; 58: 321328.
  • 29
    Hepner GW, Hofmann AF, Thomas PJ. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. I. Cholylglycine. J Clin Invest 1972; 51: 18891897.
  • 30
    Hepner GW, Hofmann AF, Thomas PJ. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. II. Glycine-conjugated dihydroxy bile acids. J Clin Invest 1972; 51: 18981905.
  • 31
    Hepner GW, Sturman JA, Hofmann AF, Thomas PJ. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. III. Cholyltaurine (taurocholic acid). J Clin Invest 1973; 52: 433440.
  • 32
    Hoffman NE, Hofmann AF. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. IV. Description and validation of a multicompartmental model. Gastroenterology 1974; 67: 887897.
  • 33
    Hoffman NE, Hofmann AF. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. V. Equations for the perturbed enterohepatic circulation and their application. Gastroenterology 1977; 72: 141148.
  • 34
    Simmonds WJ, Korman MG, Go VLW, Hofmann AF. Radioimmunoassay of conjugated cholyl bile acids in serum. Gastroenterology 1973; 65: 705711.
  • 35
    Schalm SW, van Berge Henegouwen GP, Hofmann AF, Cowen AE, Turcotte J. Radioimmunoassay of bile acids. Development, validation and preliminary application of an assay for conjugates of chenodeoxycholic acid. Gastroenterology 1977; 73: 285290.
  • 36
    LaRusso NF, Korman MG, Hoffman NE, Hofmann AF. Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption. N Engl J Med 1974; 291: 689692.
  • 37
    LaRusso NF, Hoffman NE, Korman MG, Hofmann AF, Cowen AE. Determinants of fasting and postprandial serum bile acid levels in healthy man. Am J Dig Dis 1978; 23: 385391.
  • 38
    Hofmann AF, Molino G, Milanese M, Belforte G. Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man. J Clin Invest 1983; 71: 10031022.
  • 39
    Molino G, Hofmann AF, Cravetto C, Belforte G, Bona B. Simulation of the metabolism and enterohepatic circulation of endogenous chenodeoxycholic acid in man using a physiological pharmacokinetic model. Eur J Clin Invest 1986; 16: 397414.
  • 40
    Hofmann AF, Cravetto C, Molino G, Belforte G, Bona B. Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in man using a physiological pharmacokinetic model for bile acid metabolism. Gastroenterology 1987; 93: 693709.
  • 41
    Cravetto C, Molino G, Hofmann AF, Belforte G, Bona B. Computer simulation of portal venous shunting and other isolated hepatobiliary defects of the enterohepatic circulation of bile acids using a physiological pharmacokinetic model. HEPATOLOGY 1988; 8: 866878.
  • 42
    Huijghebaert SM, Hofmann AF. Pancreatic carboxypeptidase hydrolysis of bile acid-amino acid conjugates: selective resistance of glycine and taurine amidates. Gastroenterology 1986; 90: 306315.
  • 43
    Hediger MA, Coady MJ, Ikeda TS, Wright EM. Expression cloning and cDNA sequencing of the Na+/glucose co-transporter. Nature 1987; 330: 379381.
  • 44
    Wong MH, Oelkers P, Craddock AL, Dawson PA. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J Biol Chem 1994; 269: 13401347.
  • 45
    Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerova D, Rayner A, Dutton L, et al. Severe bile salt export pump deficiency; 82 different ABCB11 mutations in 109 families. Gastroenterology 2008; 134: 12031214.
  • 46
    Oelkers P, Kirby LC, Heubi JE, Dawson PA. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest 1997; 99: 18801887.
  • 47
    Rao A, Haywood J, Craddock AL, Belinsky MG, Kruh GD, Dawson PA. The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis. Proc Natl Acad Sci U S A 2008; 105: 38913896.
  • 48
    Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005; 2: 217225.
  • 49
    Gass J, Vora H, Hofmann AF, Gray GM, Khosla C. Enhancement of dietary protein digestion by conjugated bile acids. Gastroenterology 2007; 133: 1623.
  • 50
    Hofmann AF, Eckmann L. How bile acids confer gut mucosal protection against bacteria [commentary]. Proc Natl Acad Sci U S A 2006; 103: 43334334.
  • 51
    Lorenzo-Zuniga V, Bartoli R, Planas R, Hofmann AF, Vinado B, Hagey LR, et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation and endotoxemia in cirrhotic rats. HEPATOLOGY 2003; 37: 551557.
  • 52
    Inagaki T, Moschetta A, Lee YK, Peng L, Zhao G, Downes M, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A 2006; 103: 39203925.
  • 53
    Mekhjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest 1971; 50: 15691577.
  • 54
    Keely S, Scharl M, Bertelsen LS, Hagey LR, Barrett KE, Hofmann AF. Bile acid induced secretion in polarized monolayers of T84 colonic epithelial cells: structure-activity relationships. Am J Physiol 2007; 292: G292G297.
  • 55
    Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969; 281: 397402.
  • 56
    Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 1972; 62: 918934.
  • 57
    Smith MJ, Cherian P, Raju GS, Dawson BF, Mahon S, Bardhan KD. Bile salt malabsorption in persistent diarrhoea. J R Coll Physicians Lond 2000; 34: 448451.
  • 58
    Tasleem AM, Dew T, Balesaria S, Brydon GW, Le Roux CW, Walters JR. Reduced serum fibroblast growth factor 19 (FGF19) in patients with idiopathic bile acid malabsorption. [Abstract] Gastroenterology 2008; 134: A405.
  • 59
    Gälman C, Arvidsson T, Angelin B, Rudling M. Monitoring hepatic cholesterol 7 alpha-hydroxylase activity by assay of the stable bile acid intermediate 7 alpha-hydroxy-4-cholesten-3-one in peripheral blood. J Lipid Res 2003; 44: 859866.
  • 60
    Hofmann AF, Bolder U. Detection of bile acid malabsorption by the SeHCAT test: principles, problems and clinical utility. Gastroenterol Clin Biol 1994; 18: 847851.
  • 61
    Lillienau J, Munoz J, Longmire-Cook SJ, Hagey LR, Crombie DL, Hofmann AF. Negative feedback regulation of the ileal bile acid transport system in rodents. Gastroenterology 1993; 104: 3846.
  • 62
    Hofmann AF. Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry. Gut 2003; 52: 12391241.
  • 63
    Lanzini A, De Tavonatti MG, Panarotto B, Scalia S, Mora A, Benini F, et al. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis and reverts to normal during ursodeoxycholic acid administration Gut 2003; 52: 12391241.
  • 64
    Tremont SJ, Lee SF, Huang HC, Keller BT, Banerjee SC, Both, SR, et al. Discovery of potent, nonsystemic apical sodium-codependent bile cid transporter inhibitors (Part I). J Med Chem 2005; 48: 58375852.
  • 65
    Hill AB. The environment and disease: association or causation. Proc R Soc Med 1965; 58: 295300.
  • 66
    Hofmann AF, Huet PM. Nasobiliary drainage for cholestatic pruritus. HEPATOLOGY 2006; 43: 11701171.
  • 67
    Brunner, H, Northfield TC, Hofmann AF, Go VLW, Summerskill WHJ. Gastric emptying and secretion of bile acids, cholesterol, and pancreatic enzymes during digestion: duodenal perfusion studies in healthy subjects. Mayo Clin Proc 1974; 49: 851860.
  • 68
    Schmassmann A, Angellotti MA, Ton-Nu HT, Schteingart CD, Marcus SN, Rossi SS, et al. Transport, metabolism and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation. Gastroenterology 1990; 98: 163174.
  • 69
    Schmassmann A, Fehr HF, Locher J, Lillienau J, Schteingart CD, Rossi SS, et al. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans. Gastroenterology 1993; 104: 11711181.
  • 70
    Longmire-Cook SJ, Lillienau J, Kim YS, Schteingart CD, Danzinger RG, Esch O, et al. Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption: studies in dogs with ileal resection. Dig Dis Sci 1992; 37: 12171227.
  • 71
    Lillienau J, Schteingart CD, Hofmann AF. Physicochemical and physiological properties of cholylsarcosine: a potential replacement detergent for bile acid deficiency states in the small intestine. J Clin Invest 1992; 89: 420431.
  • 72
    Kapral C, Wewalka F, Praxmarer V, Lenz K, Hofmann AF. Conjugated bile acid replacement therapy in short bowel syndrome in patients with a residual colon. Z Gastroenterol 2004; 42: 583589.
  • 73
    Hofmann AF. Separation of 1- and 2-monoglycerides by thin-layer adsorption chromatography on hydroxyl-apatite. J Lipid Res 1962; 3: 391392.
  • 74
    Schoelmerich J, van Berge Henegouwen GP, Hofmann AF, DeLuca M. A bioluminescence assay for total 3α-hydroxy bile acids in serum using immobilized enzymes. Clin Chim Acta 1984; 137: 2132.
  • 75
    Roda A, Kricka LJ, DeLuca M, Hofmann AF. Bioluminescent measurement of primary bile acids using immobilized 7α-hydroxysteroid dehydrogenase: application to serum bile acids. J Lipid Res 1982; 23: 13541361.
  • 76
    Rossi SS, Clayton LM, Hofmann AF. Determination of chenodiol bioequivalence using an immobilized multi-enzyme bioluminescence technique. J Pharm Sci 1986; 75: 288290.
  • 77
    Rossi SS, Wayne ML, Smith RB, Wright CE, Andreadis NA, Hofmann AF. Effect of the bile acid sequestrant colestipol on postprandial serum bile acid levels: evaluation by bioluminescent enzymatic analysis. Aliment Pharmacol Ther 1989; 3: 4146.
  • 78
    Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987; 28: 589595.
  • 79
    Fisher RL, Hofmann AF, Converse JL, Rossi SS, Lan S-P. Lack of relationship between hepatotoxicity and lithocholic acid sulfation during chenodiol therapy in the National Cooperative Gallstone Study. HEPATOLOGY 1991; 14: 454463.
  • 80
    Hamilton JP, Xie G, Raufman J-P, Hogan S, Griffin TL, Packard CA, et al. Bile acids of human cecal contents: concentration and spectrum Am J Physiol 2007; 293: G256G263.
  • 81
    Hofmann AF, Loening-Baucke V, Lavine JE, Hagey LR, Steinbach JH, Packard CA, et al. altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients. J Pediatr Gastroenterol Nutr 2008; 47: 598606.
  • 82
    Sjövall J. Fifty years with bile acids and steroids in health and disease. Lipids 2004; 39: 703722.
  • 83
    Allen RD, Wan IY, Wallraff GM, DiPietro RA, Hofer DC, Kunz RR. Resolution and etch resistance of a family of 193nm positive resists. J Photopolym Sci Technol 1995; 8: 623626.
  • 84
    Thudichum JLW. A Treatise on Gall-stones: Their Chemistry, Pathology, and Treatment. London, UK: John Churchill and Sons; 1863.
  • 85
    Schiff M. Il coleinata di soda nella cura dei calcoli biliary. L'Ímparziale 1873; 13: 9799.
  • 86
    Johnston CG, Nakayama F. Solubility of cholesterol and gallstones in metabolic material. Arch Surg 1957; 75: 436442.
  • 87
    Vlahcevic ZR, Bell CC, Buhac I, Farrar JT, Swell L. Diminished bile acid pool size in patients with gallstones. Gastroenterology 1970; 59: 165173.
  • 88
    Grundy SM, Hofmann AF, Davignon J, Ahrens EH Jr. Human cholesterol synthesis is regulated by bile acids. J Clin Invest 1066; 45: 10181019.
  • 89
    Danzinger RG, Hofmann AF, Schoenfield LJ, Thistle JL. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1972; 286: 18.
  • 90
    Heywood R, Palmer AK, Foll CV, Lee, MR. Pathological changes in fetal Rhesus monkey induced by oral chenodeoxycholic acid. Lancet 1973; 2: 1020.
  • 91
    Cowen AE, Korman MG, Hofmann AF, Cass OW. Metabolism of lithocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates. Gastroenterology 1975; 69: 5966.
  • 92
    Cowen AE, Korman MG, Hofmann AF, Cass OW, Coffin SB. Metabolism of lithocholate in healthy man. II. Enterohepatic circulation. Gastroenterology 1975; 69: 6776.
  • 93
    Gadacz TR, Allan RN, Mack E, Hofmann AF. Impaired lithocholate sulfation in the rhesus monkey: a possible mechanism for chenodeoxycholate toxicity. Gastroenterology 1976; 70: 11251129.
  • 94
    Schwenk M, Hofmann AF, Carlson GL, Carter JA, Coulston F, Greim H. Bile acid conjugation in the chimpanzee: effective sulfation of lithocholic acid. Arch Toxicol 1978; 40: 109118.
  • 95
    van Berge Henegouwen GP, Hofmann AF, Gaginella TS. Pharmacology of chenodeoxycholic acid. I. Pharmaceutical properties. Gastroenterology 1977; 73: 291299.
  • 96
    van Berge Henegouwen GP, Hofmann AF. Pharmacology of chenodeoxycholic acid. II. Absorption and metabolism. Gastroenterology 1977; 73: 300309.
  • 97
    Northfield TC, Hofmann AF. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects Gut 1975; 16: 1217.
  • 98
    Nilsell K, Angelin B, Liljeqvist L, Einarsson K. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients. Gastroenterology 1985; 89: 287293.
  • 99
    Lammert F, Miquel JF. Gallstone disease: from genes to evidence-based therapy. J Hepatol 2008; 48(Suppl 1): S124S135
  • 100
    Schoenfield LJ, Lachin JM, The Steering Committee, The National Cooperative Gallstone Study Group. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study. Ann Intern Med 1981; 95: 257282.
  • 101
    Lachin JM, Marks JW, Schoenfield LJ, the NCGS Protocol Committee, The National Cooperative Gallstone Study group. Design and methodological considerations in the National Cooperative Gallstone Study. A multi-center clinical trial. Control Clin Trials 1981; 2: 177229.
  • 102
    Schoenfield LJ, Grundy SM, Hofmann AF, Lachin JM, Thistle JL, Tyor MP, for the National Cooperative Gallstone Study Group. The National Cooperative Gallstone Study viewed by its investigators. Gastroenterology 1983; 84: 644648.
  • 103
    Wolpers C, Hofmann AF. Solitary versus multiple cholesterol gallbladder stones. Clin Investig 1993; 71: 423434.
  • 104
    Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D. Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med 1983; 99: 199204.
  • 105
    Ammon HV, Hofmann AF. The Langenbuch Paper. I. An historical perspective and comments of the translators. II. A translation. Gastroenterology 1983; 85: 14261433.
  • 106
    Sauter G, Kullak-Ublick GA, Schumacher R, Janssen J, Griner L, Brand B, et al. Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy. Gastroenterology 1997; 112: 16031609.
  • 107
    Thistle JL, Carlson GL, Hofmann AF, LaRusso NF, MacCarty RL, Flynn GL, et al. Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application. Gastroenterology 1980; 78: 10161022.
  • 108
    Flynn GL, Shah Y, Prakongpan S, Kwan KH, Higuchi WI, Hofmann AF. Cholesterol solubility in organic solvents. J Pharm Sci 1979; 68: 10901097.
  • 109
    Mack E, Patzer EM, Crummy AB, Hofmann AF, Babayan VK. Retained biliary tract stones. Nonsurgical treatment with Capmul 8210, a new cholesterol gallstone dissolution agent. Arch Surg 1981; 116: 341344.
  • 110
    Palmer KR, Hofmann AF. Intraductal mono-octanoin for the direct dissolution of bile duct stones: experience in 343 patients. Gut 1986; 27: 196202.
  • 111
    Thistle JL, May GR, Bender CE, Williams HJ, LeRoy AJ, Nelson PE, et al. Dissolution of cholesterol gallbladder stones by methyl tert-butyl ether administered by percutaneous transhepatic catheter N Engl Med 1989; 320: 633639.
  • 112
    Esch O, Spinosa JC, Hamilton RL, Crombie DL, Schteingart CD, Rondinone JF, et al. Acute effects on gallbladder histology of topical methyl tert-butyl ether or ethyl propionate in animals: A comparison of two solvents for contact dissolution of cholesterol gallstones. HEPATOLOGY 1992; 16: 984991.
  • 113
    Zakko SF, Hofmann AF. Microprocessor-assisted solvent transfer system for effective contact dissolution of gallbladder stones. IEEE Trans Biomed Eng 1980; 7: 410416.
  • 114
    Zakko SF, Hofmann AF. Microprocessor-assisted solvent-transfer system for gallstone dissolution: in vitro and in vivo validation. Gastroenterology 1990; 99: 18071813.
  • 115
    Hofmann AF, Schteingart CD, vanSonnenberg E, Esch O, Zakko SF. Contact dissolution of cholesterol gallstones with organic solvents. Gastroenterol Clin N Am 1991; 20: 183199.
  • 116
    Hofmann AF, Schteingart CD, Lyche K, Esch O, Amelsberg A, VanSonnenberg E, et al. Topical dissolution of cholesterol gallbladder stones using ethyl propionate: initial clinical experience. Dig Dis Sci 1997; 42: 12741282.
  • 117
    Gurantz D, Hofmann AF. Influence of bile acid structure on bile flow and biliary lipid secretion in the hamster. Am J Physiol 1984; 247: G736G748.
  • 118
    Lindstedt S, Tryding N. On the metabolism of bishomocholic, homocholic and norcholic acid in the rat. Ark Kemi 1957; 11: 137144.
  • 119
    O'Maille ERL, Kozmary SV, Hofmann AF, Gurantz D. Differing effects of norcholate and cholate on bile flow and biliary lipid secretion in the rat. Am J Physiol 1984; 246: G67G71.
  • 120
    Palmer KR, Gurantz D, Hofmann AF, Clayton LM, Hagey LR, Cecchetti S. Hypercholeresis induced by nor-chenodeoxycholate in the biliary fistula rodent. Am J Physiol 1987; 252: G219G228.
  • 121
    Yoon YB, Hagey LR, Hofmann AF, Gurantz D, Michelotti EL, Steinbach JH. Effect of side-chain shortening on the physiological properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents. Gastroenterology 1986; 90: 837852.
  • 122
    Dumont M, Erlinger S, Uchman, S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology 1980; 79: 8289.
  • 123
    Wheeler HO, Ross ED, Bradley SE. Canalicular bile production in dogs. Am J Physiol 1968; 214: 866874.
  • 124
    Hofmann AF, Zakko SF, Lira M, Clerici C, Hagey LR, Lambert KK, et al. Novel biotransformation and physiological properties of norursodeoxycholic acid in man. HEPATOLOGY 2005; 42: 13911398.
  • 125
    Bolder U, Trang NV, Hagey LR, Schteingart CD, Ton-Nu H-T, Cerrè C, et al. Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats. Gastroenterology 1999; 117: 962971.
  • 126
    Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000; 118: 422430.
  • 127
    Smith AJ, De Vree JM, Ottenhoff R, Oude Elferink RP, Schinkel AH, Borst P. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr3 (-/-) mice. HEPATOLOGY 1998; 28: 530536.
  • 128
    Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2004; 127: 261274.
  • 129
    Fickert P, Wagner M, Marschall H-U, Fuchsbichler A, Zollner G, Tsybrovskyy O, et al. 24-norUrsodeoxycholic Acid as novel therapeutic approach to sclerosing cholangitis in mdr2 (ABCB4) knockout mice. Gastroenterology 2006; 130: 465481.
  • 130
    Gotthardt D, Runz H, Keitel V, Fischer C, Flechtenmacher C, Wirtenberger M, et al. A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults. HEPATOLOGY 2008; 48: 11571166.
  • 131
    Corbechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. HEPATOLOGY 2008; 48: 871877.
  • 132
    Paumgartner G. Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression. J Hepatol 2003; 39: 1216.
  • 133
    Goulis J, Leandro G, Burroughs AK. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 1999; 354: 10531060.
  • 134
    Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. HEPATOLOGY 2005; 42: 13991405.
  • 135
    Sundaram SS, Bove KE, Lovell MA, Sokol RJ. Mechanisms of disease: Inborn errors of bile acid synthesis. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 456468.
  • 136
    Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, et al. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell 2003; 11: 10791092.
  • 137
    Soisson SM, Parthasarathy G, Adams AD, Sahoo S, Sitlani A, Sparrow C, et al. Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation. Proc Natl Acad Sci U S A 2008; 105: 53375342.
  • 138
    Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signaling for metabolic diseases. Nat Rev Drug Discov 2008; 7: 678693.
  • 139
    Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006; 439: 484489.
  • 140
    Sato H, Macchiarulo A, Thomas C, Gioiello A, Une M, Hofmann AF, et al. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem 2008; 51: 18311841.
  • 141
    Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci 2008; 65: 24612483.
  • 142
    Staels B, Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 2007; 67: 13831392.
  • 143
    Suzuki T, Oba K, Igari Y, Matsumura N, Watanabe K, Futami-Suda S, et al. Colestimide lowers plasma glucose levels and increases plasma glucagon-like peptide-1(7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia. J Nippon Med Sch 2007; 74: 338343.
  • 144
    Moschetta A, Xu F, Hagey LR, van Berge-Henegouwen GP, van Erpecum KJ, Brouwers JF, et al. A phylogenetic survey of biliary lipids in vertebrates. J Lipid Res 2005; 46: 22212232.